Literature DB >> 10594338

Acute low doses of melatonin stimulate rat sex behavior: the role of serotonin neurotransmission.

F Drago1, L Busà, A Benelli, A Bertolini.   

Abstract

Melatonin is known to inhibit male and female sex behavior, but this effect has been reported only after repeated administration of sustained doses of the hormone. The present experiments were performed in order to study the effects of acute treatment with low doses of melatonin on rat male and female sex behavior in a dose-response paradigm. After four mating tests with a receptive female, sexually active male rats of the Wistar strain were injected intraperitoneally (i.p.) with small doses of melatonin (10, 50 and 100 microg/kg) administered acutely 1 h before a 30-min mating test. Melatonin (50 and 100 ng/2 microl) or its analogs, 6-chloromelatonin (2 and 4 ng/2 microl) and 2-iodomelatonin (5 and 10 ng/2 microl) were also injected intracerebroventricularly (i.c.v.) 30 min before mating. Either treatments caused a reduction of the latency to the first mount, intromission and ejaculation. An increase in the frequency of mounts, intromissions and ejaculations was also observed. Inhibition of sexual activity was observed when a greater dose (1 mg/kg) of melatonin was repeatedly injected for 14 days. Female sex behavior, measured by the lordosis quotient in Wistar female rats, was not affected by acute treatment with the hormone, while it appeared to be inhibited by the repeated injection. The facilitating effect of acute i.p. or i.c.v. melatonin low doses on sexual activity of male rats was partially abolished by the pre-treatment with the non-selective melatonin antagonist, luzindole (0.25 mg/kg, injected subcutaneously), and totally suppressed by the injection of small quantities of serotonin or the 5H(2A)-5H(2C) receptor agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane into the amygdala. These results suggest that melatonin may exert opposite effects on male and female sex behavior depending on the dose and duration of treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594338     DOI: 10.1016/s0014-2999(99)00701-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Melatonin is involved in the modulation of the hypothalamic and pituitary activity in the South American plains vizcacha, Lagostomus maximus.

Authors:  Santiago Elías Charif; Pablo Ignacio Felipe Inserra; Alejandro Raúl Schmidt; Santiago Andrés Cortasa; Sofía Proietto; María Clara Corso; Julia Halperin; Noelia Paula Di Giorgio; Victoria Lux-Lantos; Alfredo Daniel Vitullo; Verónica Berta Dorfman
Journal:  J Comp Physiol B       Date:  2021-08-30       Impact factor: 2.200

2.  Altered sleep architecture and higher incidence of subsyndromal depression in low endogenous melatonin secretors.

Authors:  Shadab Ataur Rahman; Shai Marcu; Leonid Kayumov; Colin Michael Shapiro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-18       Impact factor: 5.270

3.  Small doses of melatonin increase intestinal motility in rats.

Authors:  Filippo Drago; Silvia Macauda; Soudabeh Salehi
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

4.  Exogenous melatonin administration affects self-grooming and conspecific odor preferences in long-photoperiod meadow voles (Microtus pennsylvanicus).

Authors:  Michael H Ferkin; Stuart T Leonard; Jerry P Gilless
Journal:  Physiol Behav       Date:  2007-03-16

Review 5.  Rapid ejaculation.

Authors:  A D Seftel; S E Althof
Journal:  Curr Urol Rep       Date:  2000-12       Impact factor: 2.862

6.  The Effect of Melatonin on Climacteric Symptoms in Menopausal Women; A Double-Blind, Randomized Controlled, Clinical Trial.

Authors:  Nehleh Parandavar; Khadijeh Abdali; Sara Keshtgar; Maasoumeh Emamghoreishi; Seddegheh Amooee
Journal:  Iran J Public Health       Date:  2014-10       Impact factor: 1.429

Review 7.  Efficacy and safety of supplemental melatonin for delayed sleep-wake phase disorder in children: an overview.

Authors:  David Mantle; Marcel Smits; Myrthe Boss; Irene Miedema; Inge van Geijlswijk
Journal:  Sleep Med X       Date:  2020-08-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.